Stay updated on Crenezumab in PSEN1 E280A Mutation Clinical Trial
Sign up to get notified when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.

Latest updates to the Crenezumab in PSEN1 E280A Mutation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed extensive details about a clinical study on Crenezumab for Alzheimer's Disease, including participant criteria and study design, while adding references to the Alzheimer's Disease and the collaborators involved in the research.SummaryDifference27%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
Stay in the know with updates to Crenezumab in PSEN1 E280A Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab in PSEN1 E280A Mutation Clinical Trial page.